OBIO · Orchestra BioMed Holdings, Inc.
Market Cap
$311.64M
Shares
60.11M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.19
Open$5.23
Day$5.06–5.23
52W close$2.35–5.66
Avg vol 30d270K
Short int2.4M · 4.0% float · 13.1d
Short vol40%
DataAug 2020–Aug 2026
Filing10-Q · Aug 10
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 10, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Strong
Sentiment
Very Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+22%
above
Price vs 50-day avg
+21%
above
RSI (14)
63
neutral
MACD trend
Positive
52-week position
86%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+30%
trailing
6-month return
+11%
trailing
YTD return
+25%
this year
Relative strength
−2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+18% holders QoQ · +25 funds added
Insider flow
Accumulating
Net +$10.7K over 90 days · 0% sells
Short interest
Falling
3.97% of float · ▼ -1.7% MoM · 13.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+1169%
Y/Y
EPS growth
+33%
Y/Y
Free cash flow
$-49.5M
Balance sheet
$19.7M
net cash
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
5.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+22%
Bullish
Price vs 50-day avg
+21%
Bullish
RSI (14)
63
Neutral
MACD trend
Positive
Bullish
52-week position
86%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 5 of 6
Trend (MA cross)
Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+18% holders QoQ · +25 funds added
Insider flow
Accumulating
Net +$10.7K over 90 days · 0% sells
Short interest
Falling
3.97% of float · ▼ -1.7% MoM · 13.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $5 · 86%
Range high $6
vs 200-day avg +22%
vs 50-day avg +21%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OBIO
this stock
Orchestra BioMed Holdings, Inc.
|
$311.64M | +24.9% | +1169.2% | — | 4.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +2.9% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OBIO | -3.3% | +30.3% | +11.0% | +30.3% | +24.9% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -3.7% | +27.3% | -2.4% | +27.3% | +12.1% |
Key facts
CIK
1814114
CUSIP
68572M106
13F (30d)
64 filings
64 filers
Visit website
Investor relations